DocGo (DCGO) investor relations material

Deal rationale and strategic fit

• Acquisition creates an end-to-end solution combining in-home and virtual care, expanding reach and efficiency across the U.S. and UK.

• SteadyMD's 50-state telehealth platform and clinician network will accelerate scaling of in-home care and primary care services.

• Enables more efficient patient care by integrating mobile health clinicians with a 600+ clinician virtual network.

• The deal addresses primary care shortages and enhances care gap closure programs for payers and patients with limited access.

• The combination enables cross-selling opportunities to each other's customer bases, including labs, payers, and health tech startups.

Financial terms and conditions

• Purchase price is up to $25 million, with an upfront payment and a contingent earnout, funded from existing cash.

• Earnout may be paid in cash or stock at the acquirer's election.

• SteadyMD is expected to generate about $25 million in revenue in 2025 and be EBITDA positive in 2026.

• Revenue model includes monthly recurring fees, per-visit or hourly fees, and monthly minimums for customers.

• 2025 revenue and adjusted EBITDA guidance will be updated to reflect the acquisition.

Synergies and expected cost savings

• Integration of SteadyMD's virtual provider network is projected to improve gross margin for in-home visits by up to 10%.

• G&A synergies identified in compliance, HR, finance, and payroll, with support from Alvarez and Marsal.

• Both gross margin and G&A synergies expected as platforms and operations are combined.

• Integration is expected to drive efficiencies in patient care delivery and optimize scalable virtual care services.